These data suggest that high doses of SM-164 plus TNFα can reduce the survival of cells from this tumor through pathways that are independent of caspases, RIPK1 and RIPK3, but because high concentrations of drugs were required to stimulate this death in vitro, such alternative pathways may not occur in vivo. The gene discussed is RIPK3; the disease is neoplasm.